Investigation Overview
January 27, 2014 (Shareholders Foundation) - An investigation on behalf of investors of Cleveland BioLabs, Inc. (NASDAQ:CBLI) shares over potential securities laws violations by Cleveland BioLabs. and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers of the...
You must register (for free) or login to view the entire investigation.